118 related articles for article (PubMed ID: 7377155)
1. Diphtheria-tetanus skin testing. Its clinical value for delayed hypersensitivity.
Kaufman DB; deMendonça WC; Newton J
Am J Dis Child; 1980 May; 134(5):479-83. PubMed ID: 7377155
[TBL] [Abstract][Full Text] [Related]
2. Cynomolgus monkeys (Macaca fascicularis) in preclinical immune function safety testing: development of a delayed-type hypersensitivity procedure.
Bleavins MR; de la Iglesia FA
Toxicology; 1995 Jan; 95(1-3):103-12. PubMed ID: 7825177
[TBL] [Abstract][Full Text] [Related]
3. Delayed hypersensitivity to tetanus toxoid in man: in vivo and in vitro studies.
Johnson C; Walls RS; Ruwoldt A
Pathology; 1983 Oct; 15(4):369-72. PubMed ID: 6674868
[TBL] [Abstract][Full Text] [Related]
4. [Intracutaneous test with tetanus toxoid--a possibility for evaluating cellular immune reaction].
Schöntube M; Thilo W; Schmitz HH
Padiatr Grenzgeb; 1986; 25(2-3):275-81. PubMed ID: 3487763
[No Abstract] [Full Text] [Related]
5. Cutaneous delayed hypersensitivity in a healthy pediatric population: diagnostic value of diptheria-tetanus toxoids.
Franz ML; Carella JA; Galant SP
J Pediatr; 1976 Jun; 88(6):975-7. PubMed ID: 1271197
[No Abstract] [Full Text] [Related]
6. Delayed hypersensitivity skin testing in the Thai adult population.
Thongngarm T; Valyasevi AM; Pattanapanyasat K; Udompunturak S
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S195-200. PubMed ID: 17718262
[TBL] [Abstract][Full Text] [Related]
7. Use of tetanus toxoid for testing cell-mediated immunity.
Whittingham S; Feery B; Mackay IR
Aust N Z J Med; 1982 Oct; 12(5):511-4. PubMed ID: 6758748
[TBL] [Abstract][Full Text] [Related]
8. Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients.
Raszka WV; Moriarty RA; Ottolini MG; Waecker NJ; Ascher DP; Cieslak TJ; Fischer GW; Robb ML
J Pediatr; 1996 Aug; 129(2):245-50. PubMed ID: 8765622
[TBL] [Abstract][Full Text] [Related]
9. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
[TBL] [Abstract][Full Text] [Related]
10. The effect of prophylaxis with chloroquine and proguanil on delayed-type hypersensitivity and antibody production following vaccination with diphtheria, tetanus, polio, and pneumococcal vaccines.
Gyhrs A; Pedersen BK; Bygbjerg I; Henrichsen J; Heron I; Petersen I; Skinhoj P
Am J Trop Med Hyg; 1991 Nov; 45(5):613-8. PubMed ID: 1951872
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous resolution of diphtheria-tetanus vaccine hypersensitivity in a pediatric population.
Bégin P; Vu MQ; Picard M; Paradis L; Des Roches A
Allergy; 2011 Nov; 66(11):1508-10. PubMed ID: 21884531
[No Abstract] [Full Text] [Related]
12. Delayed cutaneous hypersensitivity testing.
Ponte CD
South Med J; 1982 Sep; 75(9):1076-9. PubMed ID: 6981851
[TBL] [Abstract][Full Text] [Related]
13. Three suitable antigens for delayed-type hypersensitivity skin testing in a tropical country like Thailand.
Siripassorn K; Charoenwongse P; Ruxrungtham K
Asian Pac J Allergy Immunol; 2006; 24(2-3):143-52. PubMed ID: 17136880
[TBL] [Abstract][Full Text] [Related]
14. Skin hypersensitivity of the delayed type in renal transplant patients receiving azathioprine or cyclosporine.
Kimmelstiel FM; Waltzer WC; Rapaport FT
Transplant Proc; 1987 Apr; 19(2):2939-42. PubMed ID: 3551236
[No Abstract] [Full Text] [Related]
15. In vivo and in vitro cell-mediated immunity to tetanus toxoid in adults.
Fairshter RD; Thornton DB; Gottschalk HR; Slater LM; Galant SP
J Allergy Clin Immunol; 1980 Dec; 66(6):452-7. PubMed ID: 7430503
[TBL] [Abstract][Full Text] [Related]
16. Relationship between cutaneous delayed hypersensitivity and cell-mediated immunity in vitro responses assessed by diphtheria and tetanus toxoids.
Galant SP; Flod N; Shimizu I; Granger GA; Groncy CE
J Allergy Clin Immunol; 1977 Oct; 60(4):247-53. PubMed ID: 332750
[No Abstract] [Full Text] [Related]
17. Atopic allergy and delayed type hypersensitivity in Estonian children.
Julge K; Meriste S; Kemp A; Björkstén B
Clin Exp Allergy; 2002 Oct; 32(10):1420-3. PubMed ID: 12372119
[TBL] [Abstract][Full Text] [Related]
18. Screening for cell-mediated immunity in children.
Steele RW; Suttle DE; LeMaster PC; Patterson FD; Canales L
Am J Dis Child; 1976 Nov; 130(11):1218-21. PubMed ID: 984003
[TBL] [Abstract][Full Text] [Related]
19. Delayed cutaneous hypersensitivity in normals: choice of antigens and comparison to in vitro assays of cell-mediated immunity.
Gordon EH; Krouse HA; Kinney JL; Stiehm ER; Klaustermeyer WB
J Allergy Clin Immunol; 1983 Nov; 72(5 Pt 1):487-94. PubMed ID: 6355249
[TBL] [Abstract][Full Text] [Related]
20. The use of tetanus toxoid to elucidate the delayed-type hypersensitivity response in an older, immunized population.
French AL; McCullough ME; Rice KT; Schultz ME; Gordin FM
Gerontology; 1998; 44(1):56-60. PubMed ID: 9436017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
